NanoMedSyn is developing glycovectors and nanovectors for drug targeting through close collaborations with national and international health research institutes. The research and innovation are supported in part by the Occitanie region and the national research agencies, ANR, ANRT and BPI France. Whether fundamental and pluridisciplinary researches constitute the bases of our drug delivery devices, we always paid a special attention to the needs raised by patient organizations and clinical centers.